日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Editorial: The immune response to therapeutic antibodies

社论:治疗性抗体的免疫反应

Tovey, Michael G; Kromminga, Arno J; Mytych, Daniel T

Quantification of Bevacizumab Activity Following Treatment of Patients With Ovarian Cancer or Glioblastoma.

贝伐珠单抗治疗卵巢癌或胶质母细胞瘤患者后的活性定量分析

Lallemand Christophe, Ferrando-Miguel Rosa, Auer Michael, Iglseder Sarah, Czech Theresa, Gaber-Wagener Anouk, Di Pauli Franziska, Deisenhammer Florian, Tovey Michael G

A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies

一种用于定量分析治疗性抗体ADCC活性的新型系统

Lallemand, Christophe; Liang, Feifei; Staub, Flore; Simansour, Maud; Vallette, Benoit; Huang, Lue; Ferrando-Miguel, Rosa; Tovey, Michael G

Upon intranasal vesicular stomatitis virus infection, astrocytes in the olfactory bulb are important interferon Beta producers that protect from lethal encephalitis

鼻内感染水疱性口炎病毒后,嗅球中的星形胶质细胞是重要的干扰素β产生细胞,可防止致命性脑炎。

Detje, Claudia N; Lienenklaus, Stefan; Chhatbar, Chintan; Spanier, Julia; Prajeeth, Chittappen K; Soldner, Claudia; Tovey, Michael G; Schlüter, Dirk; Weiss, Siegfried; Stangel, Martin; Kalinke, Ulrich

Immunogenicity and other problems associated with the use of biopharmaceuticals

生物制药的免疫原性及其他相关问题

Tovey, Michael G; Lallemand, Christophe

TL1A: a mediator of gut inflammation

TL1A:肠道炎症的介质

Young, Howard A; Tovey, Michael G

GAAP-1: a transcriptional activator of p53 and IRF-1 possesses pro-apoptotic activity

GAAP-1:p53 和 IRF-1 的转录激活因子,具有促凋亡活性

Lallemand, Christophe; Palmieri, Marta; Blanchard, Brigitte; Meritet, Jean-Francois; Tovey, Michael G